About
Cystic Fibrosis treatment
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
563
By Phase
PHASE2/PHASE3: 2PHASE2: 1
By Status
COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05999435Lead Sponsor
Study of LAU-7b for the Treatment of Long COVID in Adults
PHASE2/PHASE3Completed
272 participants
Started: Nov 20, 2023 · Completed: Nov 30, 2024
NCT04417257Lead Sponsor
Study of LAU-7b for the Treatment of COVID-19 Disease in Adults
PHASE2/PHASE3Completed
125 participants
Started: Jun 29, 2020 · Completed: May 30, 2024
NCT03265288Lead Sponsor
Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults
PHASE2Completed
166 participants
Started: Nov 5, 2018 · Completed: Sep 15, 2021
Locations (1)
Headquarters
Montréal, QC, Canada
Map
Loading map...